Skip to content

Haemonetics HAE Blood Center — D&A

Similar metrics at other companies

Seaboard logo
SEBCorporate And Other — D&A
$3M0.0%
Campbell Soup logo
CPBMeals & Beverages — D&A
$40M-4.8%
National Healthcare logo
NHCInpatient Services — D&A
$10.41M+3.5%
Galaxy Digital Inc. Class A Common Stock logo
GLXYData Centers — D&A
$0-100%
ADMA Biologics logo
ADMAPlasma Collection Centers — D&A
$565K-30.1%
JBT Marel Corporation logo
JBTMPrepared Food and Beverage Solutions — D&A
$31M+14.8%

Other financials

Income statement

See full
Revenue$346.4M+4.8%
Gross profit$198.2M+2.7%
Operating income$67.4M+14.2%
Net income$44.7M+19.3%
EPS (diluted)$0.95+28.4%

Balance sheet

See full
Cash & equivalents$245.4M-20.0%
Total debt$1.3B-0.7%
Total equity$796.3M-3.0%
Total assets$2.4B-2.2%

Cash flow

See full
Operating cash flow$70.9M-39.1%
CapEx$17.7M+12.9%
Free cash flow$53.3M-47.2%

Valuation

See full
Market cap$3.31B-18.0%

Profitability

See full
Gross margin59%+4.0pp
Operating margin19%+5.9pp
Net margin13.3%+3.8pp
FCF margin19.5%+9.1pp

Returns & leverage

See full
Return on equity19.3%+5.2pp
Debt / equity1.6×0.0×
Current ratio+1.3×

Where this comes from

Reported directly by Haemonetics in its filing.

Tagged under the XBRL concept hae:DepreciationDepletionAndAmortizationNetOfAdjustments.

The official record: Haemonetics’s 10-K, filed May 20, 2026, on SEC EDGAR. View the filing →

Ask your AI about Haemonetics's blood center — d&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Haemonetics's blood center — D&A?
Haemonetics (HAE) reported blood center — D&A of $1.79M in Q1 2026.
How has Haemonetics's blood center — D&A changed year-over-year?
Haemonetics's blood center — D&A decreased by 28.9% year-over-year, from $2.52M to $1.79M.
What is the long-term trend for Haemonetics's blood center — D&A?
Over 2 years (2024 to 2026), Haemonetics's blood center — D&A has grown at a -26.9% compound annual growth rate (CAGR), from $13.39M to $7.16M.
What does blood center — D&A mean?
Reflects the non-cash allocation of the cost of tangible and intangible assets over their useful lives within the Blood Center segment. This metric helps investors understand the capital intensity of the segment and the ongoing reinvestment required to maintain operational infrastructure. It is a critical adjustment for calculating cash-based profitability metrics like EBITDA.